Dr Aniket Puri. OCT guided BVS for LMCA to LAD : Optimising the 'Pot'

Similar documents
Complex Coronary Interventions: Bifurcations. John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

Bifurcation stenting with BVS

DK Crush,Culotte,SKS,T or TAP. Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi

I have nothing to disclose.

PCI for Ostial Lesion

Drug Eluting Stents: Bifurcation and Left Main Approach

September Peter Barlis. Royal Brompton Hospital, London, UK

in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore

Side Branch Occlusion

ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ

Will Bioresorbable Scaffolds Change How We Think About Left Main PCI?

OCTOBER. OCT Optimised Bifurcation Event Reduction. A Nordic Baltic British clinical outcome trial

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD

Lessons for technique and stent choice

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Left main coronary artery (LMCA): The proximal segment

Why I try to avoid side branch dilatation

Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique ".

DESolve NX Trial Clinical and Imaging Results

6 th European Bifurcation Club October BUDAPEST. Kissing in simple strategy? Why and how I kiss. Y. Louvard, ICPS, Massy France

Consensus so far and what we will be focusiong on this time

Medtronic Symposium The Complex Bifurcation Patient: new insights into stent selection

Protection of side branch is essential in treating bifurcation lesions: overview

The 3 top Messages from technique Specific problems Solving

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD.

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

Basics of Angiographic Interpretation Analysis of Angiography

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

LM stenting - Cypher

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April Session: Left mains & bifurcation intervention

Welcome to the 8 th European Bifurcation Club October Barcelona

The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections. Martin B. Leon, MD

Modified Reverse CART technique in a near-ostial

Plaque Shift vs. Carina Shift Prevalence and Implication

Optimal assessment observation of intravascular ultrasound

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD

LCX. President / Director of Cardiology / New Tokyo Hospital

Eulogio Garcia MD H. U. Gregorio Marañon Madrid

FFR Fundamentals and Measurements

Percutaneous Intervention of Unprotected Left Main Disease

Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System

New Double Stent Technique

Post PCI functional testing and imaging: case based lessons from FFR React

Bifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece

Effectiveness of IVUS in Complex Cases

Contemporary therapy of bifurcation lesions

POLish Bifurcation Optimal treatment Strategy randomized Study (POLBOSS) - Interim analysis

Between Coronary Angiography and Fractional Flow Reserve

Integrated Use of IVUS and FFR for LM Stenting

Making the difference with Live Image Guidance

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience

The Tryton Side Branch System in Distal Left Main PCI

PCI for Left Anterior Descending Artery Ostial Stenosis

FFR and intravascular imaging, which of which?

Bench test : Is it still useful? Do we need standardization?

PCI for Long Coronary Lesion

EBC Rules of Bifurcation PCI

Ruofei Jia, Zening Jin, Hong Li, Jing Han. Introduction

Drug eluting balloons in CAD

Technical Characteristics of coronary prostheses(stents)

Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent. Masahiko Ochiai MD, FACC, FESC, FSCAI

Bench Insights into Bifurcation Stenting in the DES Era: An Update

FFR-guided Jailed Side Branch Intervention

Intravascular Ultrasound for Complex Cases

Drug eluting balloon for bifurcation lesion: is it useful?

Side branch occlusion in 500 ABSORB BVS

Usefulness of OCT during coronary intervention

Current DES designs and expansion capacity testing

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Left Main Intervention: Will it become standard of care?

IVUS vs FFR Debate: IVUS-Guided PCI

ReZolve2 Bioresorbable Coronary Scaffold Clinical Program Update

Upgrade of Recommendation

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

The BIO revolution: bioadsorbable stents. Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino

Non-LM bifurcation studies of importance in 2011

Complicated PTCA of Left Main Total Occlusion in NSTEMI

A Paclitaxel-Eluting Balloon for Bifurcation Lesions : Early Clinical Observations

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Stents selection and optimal implantation: sizes, design, deployment Abbott Vascular. All rights reserved.

What Coronary Specialists Teach The Vascular Community About Vessel Prep? Tony Das, MD Texas Health, Dallas Dallas, Texas

Long-term freedom from angina and

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD

For Personal Use. Copyright HMP 2013

Radiation Safety Abbott Vascular. All rights reserved.

Taking DES technology from concept to long term clinical evidence. Aurore Bouvier Global Product Manager Biosensors Europe

Catch-up Phenomenon: Insights from Pathology

BIOFREEDOM: Polymer free Biolimus A9 eluting

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017

Sirolimus Nanocrystal Balloon Based Delivery for Coronary DES ISR

Optical Coherence Tomography for Intracoronary Imaging

LEFT MAIN PERCUTANEOUS CORONARY INTERVENTION. A/Prof Koh Tian Hai Medical Director National Heart Centre, Singapore

Stent Thrombosis in Bifurcation Stenting

Stent thrombosis: How to manage it Dr Philip MacCarthy BSc PhD FRCP Consultant Cardiologist King s College Hospital, London, UK.

Bioabsorbable stents: early clinical results. Dr Angela Hoye MB ChB, PhD Senior Lecturer in Cardiology Hull & East Yorkshire Hospitals

Transcription:

OCT guided BVS for LMCA to LAD : Optimising the 'Pot' Dr Aniket Puri MD,DM,FRACP, FACC, FSCAI, FAPSIC Consultant Interventional Cardiologist Christchurch Hospital and Canterbury DHB(Univ of Otago) Christchurch,New Zealand

41yr Male with no Cardiac risk factors 4wks history of sudden onset central chest pain while exercising, associated with vague SOB, no radiation. HR 78b/min, BP 136/79, rest normal ECG showed no dynamic changes, serial TNI's negative. ETT He did 7mins 21 Sec and had some atypical chest discomfort, no chest pain. Subtle ST changes in the inferior leads, but no significant ST depression. Coronary Angiogram, the movie tells the story!!!

6 PM on Friday, some thing needs to be done Low Syntax score Looks like impending plaque rupture PCI for LMCA to LAD,( Very Little argument with that thought!!) 41 year old Prospect of many years of Metallic stent in Left Main Coronary LMCA looks 3-3.5 mm in diameter I Decided to OCT LMCA and LAD and consider ABSORB BVS!!!

ABSORB BVS for LMCA,only case reports..!! Suitability of BVS LMCA Size 3-3.5mm SB 2.5mm (max 3 mm) Medina 1,1,0 (or 0,1,0) ( scaffold area 12.6mm2 equivalent to LMCA diameter 4mm)

Potential advantages of BVS in LMCA Cage free lumen after 2 3 years Temporary SB jailing may outweigh the disadvantages from a comparatively smaller, but well apposed, scaffold. If no angio evidence of pinching of the LCx ostia with TIMI 3 flow, despite temporary overhang of a neocarina, a long term, free from restenosis result is (Could be..!!) expected, thanks to the large vessel size and high shear stress

PB 3.0 7.5Fr EAU Sheath less Wire to LAD and LCX/OM

LM mid body Max Ref V diameter 3.7mm, LAD Distal Max Ref V diameter 3.2mm

After pre dilating with a 3 mm x 15 mm @ 10 atm Balloon ABSORB BVS :3.5 x 18mm deployed at 14atm

BVS funneled nicely from LMCA to LAD

Post dilated with NC Balloon 3.75 x 12mm at 14atm

Sion wire to cross BVS strut into LCX Strut dilated -2.5 x 12mm at 8atm

LM-LAD post dilated again with NC Balloon 3.75 x 15mm at 14atm

Good Angiographic result in LMCA-LAD LCX ostia no siginificant carina shift

Good apposition in LMCA and LAD suspected malapposition at the proximal strut.!!? Guide catheter related

Proximal edge post dilated with 4.0 x 8mm balloon @ 8 atm

Final result

Single BVS strategy All pre dilated Post dilated with 0.5mm higher 6 out of 9 patients: Under expansion Acute recoil Malapposition No clinical events 9 patients

PCI of the distal LMCA High rate of TVR with increased risk of late stent thrombosis with metal stents It intriguing to test a BVS scaffold, whose total resorption is expected 18 24 months. The risk of recoil with a BVS; were not significantly higher than with metal stents BVS malapposition in fibrocalcific lesions occurs more often LM lesions behave like fibrocalcific lesions in hindrance to adequate expansion. Natural coronary vessel curvature, shown to be better preserved after BVS Therefore the true clinical meaning of under expansion and late recoil is unknown. This study showed a high rate of device under expansion/recoil, whose clinical meaning should be addressed in an adequately powered study.

SB dilatation of Absorb cause MB distortion which was corrected by MB post-dilation or low-pressure mini-kbpd The best strategy for an Absorb in most bifurcation lesions is likely to be a provisional approach. The scaffold proximal to the SB can be optimally expanded by post-dilatation with a balloon sized to the proximal vessel. Optimize the POT

BVS...in selected LMCA lesions Young patient (cage free in few years) Isolated LMCA to LAD lesion (soft lesion preferred) Small to medium sized of LMCA ( Size limitation with BVS) Lumen diameter to be considered ( rather than vessel diameter) Provisional strategy planned ( 2 stents V may be used, avoid Culotte) Small side branch ( preferably disease free, if not then Hybrid) OCT (or IVUS) to confirm scaffold apposition

ABSORB BVS is a Device looking for a Niche Indication or a selected LMCA Indication is looking for a Niche Device Will it be the norm remains to be seen... THANK YOU